Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5535)
All Articles published online
|
Aug 14, 2012 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lim JY, Yoon SO, Seol SY, Hong SW, Kim JW, Choi SH, Cho JY. Overexpression of the M2 isoform of pyruvate kinase is an adverse prognostic factor for signet ring cell gastric cancer. World J Gastroenterol 2012; 18(30): 4037-4043 [PMID: 22912555 DOI: 10.3748/wjg.v18.i30.4037] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i30/4037.htm |
| Number | Citing Articles |
| 1 |
Nan Liang, Lusi Mi, Jingting Li, Tong Li, Jun Chen, Gianlorenzo Dionigi, Haixia Guan, Hui Sun, Nadeem Sheikh. Pan‐Cancer Analysis of the Oncogenic and Prognostic Role of PKM2: A Potential Target for Survival and Immunotherapy. BioMed Research International 2023; 2023(1) doi: 10.1155/2023/3375109
|
| 2 |
Ze Zhang, Xinyue Deng, Yuanda Liu, Yahui Liu, Liankun Sun, Fangfang Chen. PKM2, function and expression and regulation. Cell & Bioscience 2019; 9(1) doi: 10.1186/s13578-019-0317-8
|
| 3 |
Zhiyan LI, Baiwei ZHAO, Deyao ZHANG, Juan DENG, Yongming CHEN, Jian ZHOU. Diallyl disulfide regulates proliferation, apoptosis and aerobic glycolysis by down-regulating PKM2 in gastric cancer cells. Minerva Biotechnology and Biomolecular Research 2021; 33(3) doi: 10.23736/S2724-542X.20.02634-8
|
| 4 |
Ning Li, Dandan Meng, Yue Xu, Ling Gao, Fengqian Shen, Xiaojing Tie, Yan Zhang, Zhenying Yi, Wenjie Shen, Zonglan Liu, Zhiqiao Xu, Paula I. Moreira. Pyruvate Kinase M2 Knockdown Suppresses Migration, Invasion, and Epithelial-Mesenchymal Transition of Gastric Carcinoma via Hypoxia-Inducible Factor Alpha/B-Cell Lymphoma 6 Pathway. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/7467104
|
| 5 |
Qing Liu, Meng Liang, Tao Liu, Lucine Vuitton, Shutao Zheng, Xiangpeng Gao, Mang Lu, Xiuling Li, Ilyar Sheyhidin, Xiaomei Lu. M2 isoform of pyruvate kinase (PKM2) is upregulated in Kazakh’s ESCC and promotes proliferation and migration of ESCC cells. Tumor Biology 2016; 37(2): 2665 doi: 10.1007/s13277-015-4073-z
|
| 6 |
Qiang Zhou, Yirui Yin, Mincheng Yu, Dongmei Gao, Jialei Sun, Zhangfu Yang, Jialei Weng, Wanyong Chen, Manar Atyah, Yinghao Shen, Qinghai Ye, Chia-Wei Li, Mien-Chie Hung, Qiongzhu Dong, Chenhao Zhou, Ning Ren. GTPBP4 promotes hepatocellular carcinoma progression and metastasis via the PKM2 dependent glucose metabolism. Redox Biology 2022; 56: 102458 doi: 10.1016/j.redox.2022.102458
|
| 7 |
Zhu Wang, Jianhua Yin, Mingxing Li, Jing Shen, Zhangang Xiao, Yueshui Zhao, Chengliang Huang, Hanyu Zhang, Zhuo Zhang, Chi Hin Cho, Xu Wu. Combination of shikonin with paclitaxel overcomes multidrug resistance in human ovarian carcinoma cells in a P-gp-independent manner through enhanced ROS generation. Chinese Medicine 2019; 14(1) doi: 10.1186/s13020-019-0231-3
|
| 8 |
Adriana Romo-Perez, Guadalupe Dominguez-Gomez, Alma Chavez-Blanco, Lucia Taja-Chayeb, Aurora Gonzalez-Fierro, Consuelo Diaz-Romero, Horacio Noe Lopez-Basave, Alfonso Duenas-Gonzalez. Progress in Metabolic Studies of Gastric Cancer and Therapeutic Implications. Current Cancer Drug Targets 2022; 22(9): 703 doi: 10.2174/1568009622666220413083534
|
| 9 |
Goran Hamid Mohammad, S. W. M. Olde Damink, Massimo Malago, Dipok Kumar Dhar, Stephen P. Pereira, Michael Muders. Pyruvate Kinase M2 and Lactate Dehydrogenase A Are Overexpressed in Pancreatic Cancer and Correlate with Poor Outcome. PLOS ONE 2016; 11(3): e0151635 doi: 10.1371/journal.pone.0151635
|
| 10 |
Wei-Ren Liu, Meng-Xin Tian, Liu-Xiao Yang, Yu-Li Lin, Lei Jin, Zhen-Bin Ding, Ying-Hao Shen, Yuan-Fei Peng, Dong-Mei Gao, Jian Zhou, Shuang-Jian Qiu, Zhi Dai, Rui He, Jia Fan, Ying-Hong Shi. PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma. Oncotarget 2015; 6(2): 846 doi: 10.18632/oncotarget.2749
|
| 11 |
Lian-Wen Yuan, Hiroharu Yamashita, Yasuyuki Seto. Glucose metabolism in gastric cancer: The cutting-edge. World Journal of Gastroenterology 2016; 22(6): 2046-2059 doi: 10.3748/wjg.v22.i6.2046
|
| 12 |
Haiyan Zhu, Hui Luo, Xuejie Zhu, Xiaoli Hu, Lihong Zheng, Xueqiong Zhu. Pyruvate kinase M2 (PKM2) expression correlates with prognosis in solid cancers: a meta-analysis. Oncotarget 2017; 8(1): 1628 doi: 10.18632/oncotarget.13703
|
| 13 |
Taro Sugiyama, Kohei Taniguchi, Nobuhisa Matsuhashi, Toshihiro Tajirika, Manabu Futamura, Tomoaki Takai, Yukihiro Akao, Kazuhiro Yoshida. MiR‐133b inhibits growth of human gastric cancer cells by silencing pyruvate kinase muscle‐splicer polypyrimidine tract‐binding protein 1. Cancer Science 2016; 107(12): 1767 doi: 10.1111/cas.13091
|
| 14 |
Tai-Kuang Chao, Tien-Shuo Huang, Yu-Ping Liao, Rui-Lan Huang, Po-Hsuan Su, Hueng-Yuan Shen, Hung-Cheng Lai, Yu-Chi Wang, Pankaj K. Singh. Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancer. PLOS ONE 2017; 12(7): e0182166 doi: 10.1371/journal.pone.0182166
|
| 15 |
Q-X Huang, J-Y Cui, H Ma, X-M Jia, F-L Huang, L-X Jiang. Screening of potential biomarkers for cholangiocarcinoma by integrated analysis of microarray data sets. Cancer Gene Therapy 2016; 23(2-3): 48 doi: 10.1038/cgt.2015.66
|
| 16 |
David C. Montrose, Lorenzo Galluzzi. Cellular Nutrient Utilization and Cancer. International Review of Cell and Molecular Biology 2019; 347: 1 doi: 10.1016/bs.ircmb.2019.07.007
|
| 17 |
Xiao‐Ling Yan, Xue‐Bin Zhang, Ran Ao, Lin Guan. Retracted: Effects of shRNA‐Mediated Silencing of PKM2 Gene on Aerobic Glycolysis, Cell Migration, Cell Invasion, and Apoptosis in Colorectal Cancer Cells. Journal of Cellular Biochemistry 2017; 118(12): 4792 doi: 10.1002/jcb.26148
|
| 18 |
Elisabet Hjerpe, Suzanne Egyhazi Brage, Joseph Carlson, Marianne Frostvik Stolt, Kjell Schedvins, Hemming Johansson, Maria Shoshan, Elisabeth Åvall-Lundqvist. Metabolic markers GAPDH, PKM2, ATP5B and BEC-index in advanced serous ovarian cancer. BMC Clinical Pathology 2013; 13(1) doi: 10.1186/1472-6890-13-30
|
| 19 |
JIAN CHEN, DI SUN, HONGJIN CHU, ZHAOHUA GONG, CHENGLIN ZHANG, BENJIAO GONG, YAN LI, NING LI, LIXIN JIANG. Screening of differential microRNA expression in gastric signet ring cell carcinoma and gastric adenocarcinoma and target gene prediction. Oncology Reports 2015; 33(6): 2963 doi: 10.3892/or.2015.3935
|
| 20 |
Hong Jae Chon, Chan Kim, Arthur Cho, Yoo Min Kim, Su Jin Jang, Bo Ok Kim, Chan Hyuk Park, Woo Jin Hyung, Joong Bae Ahn, Sung Hoon Noh, Mijin Yun, Sun Young Rha. The clinical implications of FDG-PET/CT differ according to histology in advanced gastric cancer. Gastric Cancer 2019; 22(1): 113 doi: 10.1007/s10120-018-0847-5
|
| 21 |
Kayisaier Abudurousuli, Ziruo Talihati, Sendaer Hailati, Meng Yuan Han, Muhadaisi Nuer, Nawaz Khan, Nulibiya Maihemuti, Dilihuma Dilimulati, Nuerbiye Nueraihemaiti, Jimilihan Simayi, Wenting Zhou. Investigation of target genes and potential mechanisms related to compound Xiao-ai-fei honey ointment based on network pharmacology and bioinformatics analysis. Medicine 2023; 102(32): e34629 doi: 10.1097/MD.0000000000034629
|
| 22 |
Wenjuan Li, Joan Liu, Kasey Jackson, Runhua Shi, Yunfeng Zhao, Junming Yue. Sensitizing the Therapeutic Efficacy of Taxol with Shikonin in Human Breast Cancer Cells. PLoS ONE 2014; 9(4): e94079 doi: 10.1371/journal.pone.0094079
|
| 23 |
Carmen Chak-Lui Wong, Sandy Leung-Kuen Au, Aki Pui-Wah Tse, Iris Ming-Jing Xu, Robin Kit-Ho Lai, David Kung-Chun Chiu, Larry Lai Wei, Dorothy Ngo-Yin Fan, Felice Ho-Ching Tsang, Regina Cheuk-Lam Lo, Chun-Ming Wong, Irene Oi-Lin Ng, Pankaj K. Singh. Switching of Pyruvate Kinase Isoform L to M2 Promotes Metabolic Reprogramming in Hepatocarcinogenesis. PLoS ONE 2014; 9(12): e115036 doi: 10.1371/journal.pone.0115036
|
| 24 |
Peng Yang, Guo-Bin Ding, Wen Liu, Rong Fu, Amin Sajid, Zhuoyu Li. Tannic acid directly targets pyruvate kinase isoenzyme M2 to attenuate colon cancer cell proliferation. Food & Function 2018; 9(11): 5547 doi: 10.1039/C8FO01161C
|
| 25 |
Natalie A. Lockney, Manchao Zhang, Yanzhen Lu, Sabrina C. Sopha, M. Kay Washington, Nipun Merchant, Zhiguo Zhao, Yu Shyr, A. Bapsi Chakravarthy, Fen Xia. Pyruvate Kinase Muscle Isoenzyme 2 (PKM2) Expression Is Associated with Overall Survival in Pancreatic Ductal Adenocarcinoma. Journal of Gastrointestinal Cancer 2015; 46(4): 390 doi: 10.1007/s12029-015-9764-6
|
| 26 |
Nicholas Wong, Judy Yan, Diane Ojo, Jason De Melo, Jean-Claude Cutz, Damu Tang. Changes in PKM2 Associate with Prostate Cancer Progression. Cancer Investigation 2014; 32(7): 330 doi: 10.3109/07357907.2014.919306
|
| 27 |
Filipa Macedo, Kátia Ladeira, Adhemar Longatto-Filho, Sandra F. Martins. Editor’s Pick: Pyruvate Kinase and Gastric Cancer: A Potential Marker. European Medical Journal 2018; : 42 doi: 10.33590/emj/10313567
|
| 28 |
Chloé Borde, Clémentine Dillard, Aurore L’Honoré, Frédérique Quignon, Marion Hamon, Christophe H. Marchand, Roberta Soares Faccion, Maurício G. S. Costa, Elodie Pramil, Annette K. Larsen, Michèle Sabbah, Stéphane D. Lemaire, Vincent Maréchal, Alexandre E. Escargueil. The C-Terminal Acidic Tail Modulates the Anticancer Properties of HMGB1. International Journal of Molecular Sciences 2022; 23(14): 7865 doi: 10.3390/ijms23147865
|
| 29 |
Peng Chen, Liang Lou, Bigyan Sharma, Mengchu Li, Chengliang Xie, Fen Yang, Yihang Wu, Qicai Xiao, Liqian Gao. Recent Advances on PKM2 Inhibitors and Activators in Cancer
Applications. Current Medicinal Chemistry 2024; 31(20): 2955 doi: 10.2174/0929867331666230714144851
|
| 30 |
Wen Hu, Shi-Xun Lu, Min Li, Chao Zhang, Li-Li Liu, Jia Fu, Jie-Tian Jin, Rong-Zhen Luo, Chris Zhiyi Zhang, Jing-Ping Yun. Pyruvate kinase M2 prevents apoptosis via modulating Bim stability and associates with poor outcome in hepatocellular carcinoma. Oncotarget 2015; 6(9): 6570 doi: 10.18632/oncotarget.3262
|
| 31 |
Tieying Dong, Xinmei Kang, Zhaoliang Liu, Shu Zhao, Wenjie Ma, Qijia Xuan, Hang Liu, Zhipeng Wang, Qingyuan Zhang. Altered glycometabolism affects both clinical features and prognosis of triple-negative and neoadjuvant chemotherapy-treated breast cancer. Tumor Biology 2016; 37(6): 8159 doi: 10.1007/s13277-015-4729-8
|
| 32 |
Caihong Wang, Shaosen Zhang, Jie Liu, Yang Tian, Boyuan Ma, Siran Xu, Yan Fu, Yongzhang Luo. Secreted Pyruvate Kinase M2 Promotes Lung Cancer Metastasis through Activating the Integrin Beta1/FAK Signaling Pathway. Cell Reports 2020; 30(6): 1780 doi: 10.1016/j.celrep.2020.01.037
|
| 33 |
Y-C Yang, T-Y Cheng, S-M Huang, C-Y Su, P-W Yang, J-M Lee, C-K Chen, M Hsiao, K-T Hua, M-L Kuo. Cytosolic PKM2 stabilizes mutant EGFR protein expression through regulating HSP90–EGFR association. Oncogene 2016; 35(26): 3387 doi: 10.1038/onc.2015.397
|
| 34 |
Jiangying Shi, Xiaodan Ji, Shuhua Shan, Mengyun Zhao, Cai Bi, Zhuoyu Li. The interaction between apigenin and PKM2 restrains progression of colorectal cancer. The Journal of Nutritional Biochemistry 2023; 121: 109430 doi: 10.1016/j.jnutbio.2023.109430
|
| 35 |
Kazuto Harada, Carol C. Wu, Xuemei Wang, Dilsa Mizrak Kaya, Fatemeh G. Amlashi, Masaaki Iwatsuki, Mariela A. Blum Murphy, Dipen M. Maru, Brian Weston, Jeffrey H. Lee, Jane E. Rogers, Irene Thomas, Namita Shanbhag, Manoop S. Bhutani, Wayne L. Hofstetter, Quynh-Nhu Nguyen, Jaffer A. Ajani. Total Lesion Glycolysis Assessment Identifies a Patient Fraction With a High Cure Rate Among Esophageal Adenocarcinoma Patients Treated With Definitive Chemoradiation. Annals of Surgery 2020; 272(2): 311 doi: 10.1097/SLA.0000000000003228
|
| 36 |
Atul Kumar, Mamta Singh, Dolly Sharma, Vinit Kumar, Reshma Rani. Burger's Medicinal Chemistry and Drug Discovery. 2021; : 1 doi: 10.1002/0471266949.bmc286
|
| 37 |
Jing Zhao, Fei Wang, Rong-Fu Wang. Nuclear medicine based multimodal molecular imaging facilitates precision medicine for gastrointestinal tumors. World Chinese Journal of Digestology 2024; 32(10): 727 doi: 10.11569/wcjd.v32.i10.727
|
| 38 |
Tara TeSlaa, Michael A. Teitell. Conceptual Background and Bioenergetic/Mitochondrial Aspects of Oncometabolism. Methods in Enzymology 2014; 542: 91 doi: 10.1016/B978-0-12-416618-9.00005-4
|
| 39 |
Takeharu Shiroki, Misa Yokoyama, Nobuhiro Tanuma, Ryuhei Maejima, Keiichi Tamai, Kazunori Yamaguchi, Tomoyuki Oikawa, Tetsuya Noguchi, Koh Miura, Tsuneaki Fujiya, Hiroshi Shima, Ikuro Sato, Naoko Murata‐Kamiya, Masanori Hatakeyama, Katsunori Iijima, Tooru Shimosegawa, Kennichi Satoh. Enhanced expression of the M2 isoform of pyruvate kinase is involved in gastric cancer development by regulating cancer‐specific metabolism. Cancer Science 2017; 108(5): 931 doi: 10.1111/cas.13211
|
| 40 |
YONGHUA SHEN, MIN CHEN, SHULING HUANG, XIAOPING ZOU. Pantoprazole inhibits human gastric adenocarcinoma SGC-7901 cells by downregulating the expression of pyruvate kinase M2. Oncology Letters 2016; 11(1): 717 doi: 10.3892/ol.2015.3912
|
| 41 |
HISATAKA OGAWA, HIROAKI NAGANO, MASAMITSU KONNO, HIDETOSHI EGUCHI, JUN KOSEKI, KOICHI KAWAMOTO, NAOHIRO NISHIDA, HUGH COLVIN, AKIRA TOMOKUNI, YOSHITO TOMIMARU, NAOKI HAMA, HIROSHI WADA, SHIGERU MARUBASHI, SHOGO KOBAYASHI, MASAKI MORI, YUICHIRO DOKI, HIDESHI ISHII. The combination of the expression of hexokinase 2 and pyruvate kinase M2 is a prognostic marker in patients with pancreatic cancer. Molecular and Clinical Oncology 2015; 3(3): 563 doi: 10.3892/mco.2015.490
|
| 42 |
Kohei Taniguchi, Yuko Ito, Nobuhiko Sugito, Minami Kumazaki, Haruka Shinohara, Nami Yamada, Yoshihito Nakagawa, Tarou Sugiyama, Manabu Futamura, Yoshinori Otsuki, Kazuhiro Yoshida, Kazuhisa Uchiyama, Yukihiro Akao. Organ-specific PTB1-associated microRNAs determine expression of pyruvate kinase isoforms. Scientific Reports 2015; 5(1) doi: 10.1038/srep08647
|
| 43 |
Chao Wang, Jinling Jiang, Jun Ji, Qu Cai, Xuehua Chen, Yingyan Yu, Zhenggang Zhu, Jun Zhang. PKM2 promotes cell migration and inhibits autophagy by mediating PI3K/AKT activation and contributes to the malignant development of gastric cancer. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-03031-1
|
| 44 |
Kohei Taniguchi, Nobuhiko Sugito, Minami Kumazaki, Haruka Shinohara, Nami Yamada, Nobuhisa Matsuhashi, Manabu Futamura, Yuko Ito, Yoshinori Otsuki, Kazuhiro Yoshida, Kazuhisa Uchiyama, Yukihiro Akao. Positive feedback of DDX6/c-Myc/PTB1 regulated by miR-124 contributes to maintenance of the Warburg effect in colon cancer cells. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2015; 1852(9): 1971 doi: 10.1016/j.bbadis.2015.06.022
|
| 45 |
HIROSHI SAWAYAMA, TAKATSUGU ISHIMOTO, HIDETAKA SUGIHARA, NOBUTOMO MIYANARI, YUJI MIYAMOTO, YOSHIFUMI BABA, NAOYA YOSHIDA, HIDEO BABA. Clinical impact of the Warburg effect in gastrointestinal cancer (Review). International Journal of Oncology 2014; 45(4): 1345 doi: 10.3892/ijo.2014.2563
|
| 46 |
Giuseppe Biamonti, Lucia Maita, Alessandra Montecucco. The Krebs Cycle Connection: Reciprocal Influence Between Alternative Splicing Programs and Cell Metabolism. Frontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00408
|
| 47 |
Nan Li, Lin Feng, Hui Liu, Jiadong Wang, Moses Kasembeli, My Kim Tran, David J. Tweardy, Steven Hsesheng Lin, Junjie Chen. PARP Inhibition Suppresses Growth of EGFR-Mutant Cancers by Targeting Nuclear PKM2. Cell Reports 2016; 15(4): 843 doi: 10.1016/j.celrep.2016.03.070
|
| 48 |
Ze Qian, Wendi Hu, Zhen Lv, Hua Liu, Diyu Chen, Yacong Wang, Jian Wu, Shusen Zheng. PKM2 upregulation promotes malignancy and indicates poor prognosis for intrahepatic cholangiocarcinoma. Clinics and Research in Hepatology and Gastroenterology 2020; 44(2): 162 doi: 10.1016/j.clinre.2019.06.008
|
| 49 |
Le-Yi Wang, Yun-Peng Liu, Li-Gang Chen, Yan-Ling Chen, Li Tan, Jing-Jing Liu, Amarsanaa Jazag, Jian-Lin Ren, Bayasi Guleng, Hiromu Suzuki. Pyruvate Kinase M2 Plays a Dual Role on Regulation of the EGF/EGFR Signaling via E-Cadherin-Dependent Manner in Gastric Cancer Cells. PLoS ONE 2013; 8(6): e67542 doi: 10.1371/journal.pone.0067542
|
| 50 |
Akiko Suzuki, Sachin Puri, Pamela Leland, Ankit Puri, Tarsem Moudgil, Bernard A. Fox, Raj K. Puri, Bharat H. Joshi, Aamir Ahmad. Subcellular compartmentalization of PKM2 identifies anti-PKM2 therapy response in vitro and in vivo mouse model of human non-small-cell lung cancer. PLOS ONE 2019; 14(5): e0217131 doi: 10.1371/journal.pone.0217131
|
| 51 |
Nicholas Wong, Jason De Melo, Damu Tang. PKM2, a Central Point of Regulation in Cancer Metabolism. International Journal of Cell Biology 2013; 2013: 1 doi: 10.1155/2013/242513
|
| 52 |
Haili Wu, Peng Yang, Wanglai Hu, Yingying Wang, Yangxu Lu, Lichao Zhang, Yongsheng Fan, Hong Xiao, Zhuoyu Li. Overexpression of PKM2 promotes mitochondrial fusion through attenuated p53 stability. Oncotarget 2016; 7(47): 78069 doi: 10.18632/oncotarget.12942
|
| 53 |
Annamaria Ruzzo, Francesco Graziano, Irene Bagaloni, Maria Di Bartolomeo, Michele Prisciandaro, Giuseppe Aprile, Elena Ongaro, Bruno Vincenzi, Giuseppe Perrone, Daniele Santini, Lorenzo Fornaro, Caterina Vivaldi, Gianluca Tomasello, Fotios Loupakis, Sara Lonardi, Matteo Fassan, Michele Valmasoni, Donatella Sarti, Paola Lorenzini, Vincenzo Catalano, Renato Bisonni, Michela Del Prete, Guido Collina, Mauro Magnani. Glycolytic competence in gastric adenocarcinomas negatively impacts survival outcomes of patients treated with salvage paclitaxel-ramucirumab. Gastric Cancer 2020; 23(6): 1064 doi: 10.1007/s10120-020-01078-0
|
| 54 |
Ming-Chuan Hsu, Wen-Chun Hung. Pyruvate kinase M2 fuels multiple aspects of cancer cells: from cellular metabolism, transcriptional regulation to extracellular signaling. Molecular Cancer 2018; 17(1) doi: 10.1186/s12943-018-0791-3
|
| 55 |
Cheng Zhan, Li Yan, Lin Wang, Jun Ma, Wei Jiang, Yongxing Zhang, Yu Shi, Qun Wang, Carol J Wilusz. Isoform Switch of Pyruvate Kinase M1 Indeed Occurs but Not to Pyruvate Kinase M2 in Human Tumorigenesis. PLOS ONE 2015; 10(3): e0118663 doi: 10.1371/journal.pone.0118663
|
| 56 |
Yu-Ju Lai, Yu-Ching Chou, Yi-Jia Lin, Mu-Hsien Yu, Yu-Che Ou, Po-Wei Chu, Chia-Chun Wu, Yu-Chi Wang, Tai-Kuang Chao. Pyruvate Kinase M2 Expression: A Potential Metabolic Biomarker to Differentiate Endometrial Precancer and Cancer that is Associated with Poor Outcomes in Endometrial Carcinoma. International Journal of Environmental Research and Public Health 2019; 16(23): 4589 doi: 10.3390/ijerph16234589
|
| 57 |
Shruti Desai, Minming Ding, Bin Wang, Zhimin Lu, Qi Zhao, Kenna Shaw, W.K. Alfred Yung, John N. Weinstein, Ming Tan, Jun Yao. Tissue-specific isoform switch and DNA hypomethylation of the pyruvate kinase PKM gene in human cancers. Oncotarget 2014; 5(18): 8202 doi: 10.18632/oncotarget.1159
|
| 58 |
Saleha Anwar, Anas Shamsi, Taj Mohammad, Asimul Islam, Md. Imtaiyaz Hassan. Protein Kinase Inhibitors. 2022; : 199 doi: 10.1016/B978-0-323-91287-7.00027-2
|
| 59 |
Nicholas Wong, Diane Ojo, Judy Yan, Damu Tang. PKM2 contributes to cancer metabolism. Cancer Letters 2015; 356(2): 184 doi: 10.1016/j.canlet.2014.01.031
|
| 60 |
Guofeng Yue, Xia Sun, Ana Gimenez-Capitan, Jie Shen, Lixia Yu, Cristina Teixido, Wenxian Guan, Rafael Rosell, Baorui Liu, Jia Wei. TAZIs Highly Expressed in Gastric Signet Ring Cell Carcinoma. BioMed Research International 2014; 2014: 1 doi: 10.1155/2014/393064
|
| 61 |
Shuichi Fukuda, Hiroshi Miyata, Yasuhiro Miyazaki, Tomoki Makino, Tsuyoshi Takahashi, Yukinori Kurokawa, Makoto Yamasaki, Kiyokazu Nakajima, Shuji Takiguchi, Masaki Mori, Yuichiro Doki. Pyruvate Kinase M2 Modulates Esophageal Squamous Cell Carcinoma Chemotherapy Response by Regulating the Pentose Phosphate Pathway. Annals of Surgical Oncology 2015; 22(S3): 1461 doi: 10.1245/s10434-015-4522-3
|
| 62 |
Adriana Romo-Perez, Guadalupe Dominguez-Gomez, Alma Chavez-Blanco, Lucia Taja-Chayeb, Aurora Gonzalez-Fierro, Elisa Garcia-Martinez, Jose Correa-Basurto, Alfonso Duenas-Gonzalez. BAPST. A Combo of Common Use Drugs as Metabolic Therapy for
Cancer: A Theoretical Proposal. Current Molecular Pharmacology 2022; 15(6): 815 doi: 10.2174/1874467214666211006123728
|
| 63 |
|
| 64 |
Min Yu, Shengying Chen, Weifeng Hong, Yujun Gu, Bowen Huang, Ye Lin, Yu Zhou, Haosheng Jin, Yanying Deng, Lei Tu, Baohua Hou, Zhixiang Jian. Prognostic role of glycolysis for cancer outcome: evidence from 86 studies. Journal of Cancer Research and Clinical Oncology 2019; 145(4): 967 doi: 10.1007/s00432-019-02847-w
|
| 65 |
Gaojie Song, Chao Shang, Yilong Zhu, Zhiru Xiu, Yaru Li, Xia Yang, Chenchen Ge, Jicheng Han, Ningyi Jin, Yiquan Li, Xiao Li, Jinbo Fang. Apoptin Inhibits Glycolysis and Regulates Autophagy by Targeting
Pyruvate Kinase M2 (PKM2) in Lung Cancer A549 Cells. Current Cancer Drug Targets 2024; 24(4): 411 doi: 10.2174/1568009623666221025150239
|
| 66 |
Melissa M. Grant. Pyruvate Kinase, Inflammation and Periodontal Disease. Pathogens 2021; 10(7): 784 doi: 10.3390/pathogens10070784
|